Dr. Vogelzang, MD, FASCO, FACP
Dr. Nicholas Vogelzang, MD, FASCO, FACP has dedicated his professional life to researching and treating rare forms of cancer. He revolutionized mesothelioma treatment by discovering the first life-extending treatment for the disease. This chemotherapy drug combination of ALIMTA and Cisplatin continues to be the standard of care today.
American Association of Cancer Research
American College of Physicians
American Society of Clinical Oncology
American Urological Association
Chicago Urological Society
Clark County Medical Society
European Society for Medical Oncology
International Association for the Study of Lung Cancer
Kidney Cancer Association
Mesothelioma Applied Research Foundation
Nevada Oncology Society
Society of Urologic Oncology
You will have access to a world-renowned oncologist in the field of mesothelioma
Dr. Vogelzang, MD, FASCO, FACP has published over 100 articles on mesothelioma and is the co-author and co-editor of “Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies.” With hundreds of speaking engagements worldwide, he continues advancing initiatives to eradicate mesothelioma.